Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis (Z-SEA-SIDE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Francesco Burzotta, Catholic University of the Sacred Heart
ClinicalTrials.gov Identifier:
NCT01200693
First received: June 10, 2010
Last updated: February 13, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):